International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2023
Patient preference for PNH treatments: analysis from the Q-methodology of treatment attributes
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.